Datasets

HealthData.Gov

Losartan and diabetic nephropathy: commentaries on the RENAAL study

The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed to…